Topical administration of the kappa opioid receptor agonist nalfurafine suppresses corneal neovascularization and inflammation

Topical administration of the kappa opioid receptor agonist nalfurafine suppresses corneal neovascularization and inflammation

Abstract Corneal neovascularization (CNV) causes higher-order aberrations, corneal edema, ocular inflammation, and corneal transplant rejection, thereby decreasing visual acuity. In this study, we investigated the effects of topical administration of the kappa opioid receptor agonist nalfurafine (TR...

Full description

Saved in:
Bibliographic Details
Main Authors: Hurramhon Shokirova, Takenori Inomata, Tsuyoshi Saitoh, Jun Zhu, Kenta Fujio, Yuichi Okumura, Ai Yanagawa, Keiichi Fujimoto, Jaemyoung Sung, Atsuko Eguchi, Maria Miura, Ken Nagino, Kunihiko Hirosawa, Mizu Kuwahara, Yasutsugu Akasaki, Hiroshi Nagase, Akira Murakami
Format: article
Language:EN
Published: Nature Portfolio 2021
Subjects:
Medicine
R
Science
Q
Online Access:https://doaj.org/article/3ae6a01079114237a7e64390f3ffeccb
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doaj.org/article/3ae6a01079114237a7e64390f3ffeccb

Similar Items